ALEXANDRIA, Va., Oct. 13 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'OCREVUS OFRII' in its latest official gazette. The trademark application with the serial number 50015308 was filed on Jul. 27, 2026.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations containing ocrelizumab for the treatment of multiple sclerosis, pre-filled on-body injectors containing pharmaceutical preparations for the treatment of multiple sclerosis.
10 -...
International/US Class(es): 5, 10
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Genentech, Inc. 1 DNA Way South San Francisco CA California ...